EU
Emory University Portfolio holdings
AUM
$27.7M
This Quarter Return
+4.23%
1 Year Return
+31.53%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$153M
AUM Growth
+$153M
(+1.4%)
Cap. Flow
+$572K
Cap. Flow
% of AUM
0.37%
Top 10 Holdings %
Top 10 Hldgs %
48.62%
Holding
52
New
6
Increased
15
Reduced
19
Closed
6
Top Buys
| 1 |
Solid Biosciences
SLDB
|
$3.29M |
| 2 |
Travere Therapeutics
TVTX
|
$2.8M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
$2.61M |
| 4 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$2.58M |
| 5 |
Madrigal Pharmaceuticals
MDGL
|
$2.44M |
Top Sells
| 1 |
ABMD
Abiomed Inc
ABMD
|
$2.89M |
| 2 |
CORI
Corium International, Inc.
CORI
|
$2.2M |
| 3 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$2.2M |
| 4 |
KALA BIO
KALA
|
$2.12M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$2.1M |
Sector Composition
| 1 | Healthcare | 49.75% |
| 2 | Financials | 31.55% |
| 3 | Consumer Discretionary | 7% |
| 4 | Industrials | 2.82% |
| 5 | Communication Services | 1.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Berkshire Hathaway Class A
BRK.A
$1.09T
| $37.4M | 24.5% | 117 | – | – |
|
2
JD.com
JD
$44.1B
| $10.4M | 6.79% | 397,578 | – | – |
|
3
Acadia Pharmaceuticals
ACAD
$4.38B
| $4.08M | 2.67% | 196,601 +52,476 | +36% | +$1.09M |
|
|
MYOV
4
DELISTED
Myovant Sciences Ltd.
MYOV
| $3.37M | 2.2% | 126,800 +3,745 | +3% | +$99.4K |
|
|
GHDX
5
DELISTED
Genomic Health, Inc.
GHDX
| $3.36M | 2.2% | 47,803 -22,667 | -32% | -$1.59M |
|
|
6
Solid Biosciences
SLDB
$427M
| $3.29M | 2.15% | +69,785 | New | +$3.29M |
|
|
ALXN
7
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $3.2M | 2.09% | 23,015 +934 | +4% | +$130K |
|
|
DBVT
8
DBV Technologies
DBVT
$264M
| $3.11M | 2.04% | 138,447 +29,768 | +27% | +$669K |
|
9
InflaRx
IFRX
$108M
| $3.1M | 2.03% | 90,437 +12,883 | +17% | +$442K |
|
|
BHVN
10
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $2.96M | 1.94% | 78,838 -11,113 | -12% | -$417K |
|
11
Neurocrine Biosciences
NBIX
$13.8B
| $2.89M | 1.89% | 23,485 -5,334 | -19% | -$656K |
|
|
ONC
12
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $2.87M | 1.88% | 16,642 +2,321 | +16% | +$400K |
|
|
ZGNX
13
DELISTED
Zogenix, Inc.
ZGNX
| $2.85M | 1.86% | 57,374 -12,372 | -18% | -$614K |
|
14
Wave Life Sciences
WVE
$1.53B
| $2.82M | 1.85% | 56,403 -11,522 | -17% | -$576K |
|
|
15
Travere Therapeutics
TVTX
$1.56B
| $2.8M | 1.83% | +97,510 | New | +$2.8M |
|
|
SGEN
16
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.76M | 1.81% | 35,834 -10,900 | -23% | -$841K |
|
17
Ascendis Pharma
ASND
$11.8B
| $2.73M | 1.78% | 38,486 -2,042 | -5% | -$145K |
|
18
Incyte
INCY
$16.5B
| $2.67M | 1.75% | 38,637 -1,194 | -3% | -$82.5K |
|
|
ECYT
19
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $2.64M | 1.73% | 148,628 -56,667 | -28% | -$1.01M |
|
20
BioMarin Pharmaceuticals
BMRN
$11.2B
| $2.61M | 1.71% | 26,940 -3,250 | -11% | -$315K |
|
|
IMMU
21
DELISTED
Immunomedics Inc
IMMU
| $2.61M | 1.71% | +125,252 | New | +$2.61M |
|
|
MNTA
22
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $2.58M | 1.69% | +98,084 | New | +$2.58M |
|
|
SAGE
23
DELISTED
Sage Therapeutics
SAGE
| $2.54M | 1.66% | 17,998 +2,503 | +16% | +$354K |
|
24
Amicus Therapeutics
FOLD
$2.34B
| $2.45M | 1.6% | 202,726 +20,683 | +11% | +$250K |
|
|
25
Madrigal Pharmaceuticals
MDGL
$9.76B
| $2.44M | 1.6% | +11,391 | New | +$2.44M |
|